February 4 - 9, 2018
Grand Hyatt Kauai, Hawaii

 

Don't Miss Out. Register Now.

CME/CE Credit

CONTINUING EDUCATION

PHYSICIANS
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Louisville and Skin Disease Education Foundation/ Global Academy for Medical Education, LLC. The University of Louisville is accredited by the ACCME to provide continuing education for physicians.

The University of Louisville Office of Continuing Medical Education & Professional Development designates this live activity for a maximum of 34 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity

AAD RECOGNITION
Skin Disease Education Foundation’s 42nd Hawaii Dermatology Seminar (Program #394100) is recognized by the American Academy of Dermatology for 34 AAD Recognized Credits and may be used toward the American Academy of Dermatology’s Continuing Medical Education Award.

SDEF MOC-D
The self-assessment program offered at the 42nd Hawaii Dermatology Seminar is approved by the American Board of Dermatology (ABD) for MOC-D self-assessment points.

AAFP CREDIT
This Live activity, Skin Disease Education Foundation’s 42nd Annual Hawaii Dermatology Seminar, with a beginning date of 02/04/2018, has been
reviewed and is acceptable for up to 34.00 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSES
Postgraduate Institute for Medicine is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This educational activity for 34 contact hours is provided by Postgraduate Institute for Medicine. Pharmacotherapy contact hours for Advance Practice Registered Nurses will be designated on your certificate.

PHARMACISTS
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy.

 

Education as a provider of continuing pharmacy education. Postgraduate Institute for Medicine designates this continuing education activity for 34 contact hours (3.40 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number(s)- to be listed on the handout.)

 

LEARNING OBJECTIVES

At the conclusion of this live conference, participants should be better able to:

  • Integrate into daily practice evidence based recommendations on new and emerging therapies for common dermatologic diseases.
  • Implement updated strategies for managing acne, rosacea, atopic dermatitis, contact dermatitis and actinic keratosis.
  • Explain the roles of currently available biologic agents in the treatment of psoriasis and psoriatic arthritis, and appropriately incorporate newer biologics into therapeutic practice as these become available.
  • Describe the mechanisms of action, efficacy, and safety of the biologic agents used to treat psoriasis, as well as the factors involved in appropriate patient selection.
  • Assess patients for comorbidities and manage psoriasis as well as associated comorbidities.
  • Compare treatment options for hidradenitis suppurativa.
  • Diagnose and manage patients with vitiligo.
  • Describe the pathophysiology of keloids.
  • Develop a strategy for the optimal management of atopic dermatitis, including rotational regimen.
  • Describe the rationales and mechanisms of action of the new and emerging therapies for AD, particularly the recently approved and emerging agents.
  • Analyze treatment approaches for the pediatric patient with common as well as complex skin diseases.
  • Incorporate the recent research advances in understanding and treating pediatric dermatology issues such as atopic dermatitis and pediatric acne.
  • Discuss new approaches to therapy including pathway targeted therapy in the treatment of melanoma.
  • Assess the role of diagnostic tools and technology in diagnosis and detection of skin cancers.
  • Recognize the factors that are important in selecting appropriate filler agents for treating different areas of the face and targeted planar depths.
  • Compare and contrast the efficacy and safety of agents, devices, and techniques currently available in aesthetic and procedural dermatology.
  • Determine the appropriate nonsurgical techniques for facial rejuvenation based on an enhanced understanding of facial anatomy.
  • Examine energy-based technology for body contouring and discuss appropriate patient selection criteria for utilizing these devices.
  • Evaluate the role of dermoscopy in clinical practice and demonstrate enhanced skill in using this technique to diagnose dermatologic disorders.
  • Analyze emerging treatments for onychomycosis.

 

FACULTY DISCLOSURES

As a provider accredited by the ACCME, it is the policy of the University of Louisville Office of Continuing Medical Education & Professional Development to require the disclosure of anyone who is in a position to control the content of an educational activity. All relevant financial relationships with any commercial interests and/or manufacturers will be disclosed to participants at the beginning of the activity.

 

SPECIAL NEEDS

We encourage participation by all individuals. If you have a disability, advance notification of any special needs will help us better serve you. Please contact Global Academy for Medical Education at least 3 weeks in advance at 312.965.8006 or t.rillo@globalacademycme.com

Follow Us

Jointly Provided By